(A) OS, (B) EFS, (C) DOR, and (D) DBA outcomes of infused cohort. OS and EFS estimates in all infused, evaluable patients. DOR and DBA estimates in patients who achieved morphologic remission. DBA, duration of B-cell aplasia; DOR, duration of remission; EFS, event-free survival; OS, overall survival.